Sponsor or institution
Clinical trials and research at Mapp Biopharmaceutical, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $1.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Potent human monoclonal antibody for RSV prevention in people of all ages
A new one-dose monoclonal antibody (MBP002) is being developed to protect people from RSV, including infants, children, adults, and older adults.
-
A new treatment for dengue using combined antibodies
This study is working on a new treatment for dengue fever that combines two powerful antibodies into one, making it stronger and easier to produce, so it can help kids and others affected by the disease feel better with a smaller dose.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.